← Leaderboards
Mai Elmallah
University Of Florida
$6,605,741
Attributed
$8,068,748
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,068,748 · 8
By mechanism
R01$3,754,863 · 3
R38$1,622,280 · 1
P01$1,112,000 · 1
R21$889,875 · 2
K08$689,730 · 1
Top collaborators
- David H Harpole5 shared
- Scott M Palmer5 shared
- Aleksandra Tata1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Barry J. Byrne$9,633,932
- David D Fuller$12,096,681
- Nicholas Muzyczka$10,997,810
- Darin J Falk$1,302,158
- Matthew S. Gentry$17,365,380
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMouse ModelRespiratoryGene TherapyBreathingGenesEvaluationNovel TherapeuticsAffectLungPathologyMuscleMotor NeuronsRespiratory InsufficiencySeriesInnovationRespiratory MusclesFda ApprovedRespiratory PhysiologyAutomobile DrivingMutationDependovirusRespiratory FailureNovel Strategies
Grant awards (28)
Alveolar injury and repair in Pompe Disease$762,974
R01 · FY2025 · HL · contact PI
Optimizing Gene Therapy for Respiratory Insufficiency in Duchenne Muscular Dystrophy$648,119
R01 · FY2025 · HL · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$314,820
R38 · FY2025 · HL
Optimizing Gene Therapy for Respiratory Insufficiency in Duchenne Muscular Dystrophy$610,819
R01 · FY2024 · HL · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$308,524
R38 · FY2024 · HL
Targeted Therapy for Pompe Disease$345,413
R01 · FY2023 · HD · contact PI
Stimulating Access to Research in Residency (StARR) - NHLBI$314,820
R38 · FY2023 · HL
Targeted Therapy for Pompe Disease$345,413
R01 · FY2022 · HD · contact PI
Targeted Therapy for Pompe Disease$345,413
R01 · FY2021 · HD · contact PI
Duke Resident Physician-Scientist Program- NHLBI$339,431
R38 · FY2021 · HL
Respiratory Dysfunction in an Optineurin knock out ALS mouse model$442,750
R21 · FY2020 · NS · contact PI
Targeted Therapy for Pompe Disease$348,356
R01 · FY2020 · HD · contact PI
Duke Resident Physician-Scientist Program- NHLBI$344,685
R38 · FY2020 · HL
Respiratory Physiology Core$251,250
P01 · FY2020 · HL · contact PI
Targeted Therapy for Pompe Disease$348,356
R01 · FY2019 · HD · contact PI
Respiratory Physiology Core$247,875
P01 · FY2019 · HL · contact PI
Respiratory Physiology Core$205,875
P01 · FY2018 · HL · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$162,136
K08 · FY2018 · HD · contact PI
Respiratory Physiology Core$226,125
P01 · FY2017 · HL · contact PI
Gene Therapy for Upper Airway and Respiratory Insufficiency in an ALS Mouse Model$209,375
R21 · FY2017 · NS · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$124,532
K08 · FY2017 · HD · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$37,749
K08 · FY2017 · HD · contact PI
Gene Therapy for Upper Airway and Respiratory Insufficiency in an ALS Mouse Model$237,750
R21 · FY2016 · NS · contact PI
Respiratory Physiology Core$180,875
P01 · FY2016 · HL · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$121,771
K08 · FY2016 · HD · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$121,771
K08 · FY2015 · HD · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$107,731
K08 · FY2014 · HD · contact PI
Novel Approaches for Correcting Respiratory Insufficiency in Pompe Disease$14,040
K08 · FY2014 · HD · contact PI